Pamela Dewis
Pam joined Sheffield Hallam in 2006 and teaches on the BA (Honours) Early Childhood Studies degree
Development of Accelerometry for Examinations in Skeletal Surgeries
This project aims to analyse patient's posture and pattern of movement before and after skeletal surgeries.
David Binney
I am a principal lecturer of physiology and research skills and postgraduate academic delivery lead for sport
Rituals of Self Design
In the quest for an optimised body that incarnates beauty, wealth, health, and success, a growing number of individuals across social sectors are engaging in practices of body modification. With the advances in medical research and the popularisation of surgery, the body becomes a luxury item, a malleable design matter, which can be sculpted, sucked, lifted and invested into.
“By the time I graduated, I had over a year’s experience in the pharmaceutical industry and programming.”
“By the time I graduated, I had over a year’s experience in the pharmaceutical industry and programming.”
Adrian Hall
Dr Adrian Hall is a Senior Lecturer in Molecular Biology here at Sheffield Hallam University.
Anthony Walker
Staff profile for Anthony Walker
Sheffield Hallam University and Guildhawk maintain their close partnership, and are now Enhancing AI with Multilingual Data
This pioneering collaboration aims to revolutionise the way datasets are used for training machine learning models. The focus is upon multilingual work essential in sectors such as medical, engineering, and safety. Inadequate or biased labelling can lead to AI 'hallucinations' – generating incorrect or prejudiced responses – which can have dire consequences in high-stakes industries.
Jamie Broadbent
Jamie Broadbent
Using seismography and AI to help improve access to key health data in patients with coronary artery disease
We are currently working with VentriJect – a Danish medical device manufacturer. The main objective of this project is to test the validity of a device designed to estimate cardiorespiratory fitness (CRF) while a person is at rest. VentriJect have previously demonstrated the device’s validity in a healthy population. The current project will focus on people with coronary artery disease.